BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34108409)

  • 1. Differences in Cardiac Magnetic Resonance Imaging Markers Between Patients With COVID-19-associated Myocardial Injury and Patients With Clinically Suspected Myocarditis.
    Maurus S; Weckbach LT; Marschner C; Kunz WG; Ricke J; Kazmierczak PM; Bieber S; Brado J; Kraechan A; Hellmuth JC; Hausleiter J; Massberg S; Grabmaier U; Curta A
    J Thorac Imaging; 2021 Sep; 36(5):279-285. PubMed ID: 34108409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac involvement in consecutive elite athletes recovered from Covid-19: A magnetic resonance study.
    Małek ŁA; Marczak M; Miłosz-Wieczorek B; Konopka M; Braksator W; Drygas W; Krzywański J
    J Magn Reson Imaging; 2021 Jun; 53(6):1723-1729. PubMed ID: 33474768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques.
    Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in T1 and T2 Mapping in the Assessment of Fulminant Myocarditis by Cardiac Magnetic Resonance.
    Wheen P; Armstrong R; Daly CA
    Curr Cardiol Rep; 2020 May; 22(7):47. PubMed ID: 32472218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric cardiac magnetic resonance imaging in pediatric and adolescent patients with acute myocarditis.
    Isaak A; Bischoff LM; Faron A; Endler C; Mesropyan N; Sprinkart AM; Pieper CC; Kuetting D; Dabir D; Attenberger U; Luetkens JA
    Pediatr Radiol; 2021 Dec; 51(13):2470-2480. PubMed ID: 34435226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury.
    Weckbach LT; Curta A; Bieber S; Kraechan A; Brado J; Hellmuth JC; Muenchhoff M; Scherer C; Schroeder I; Irlbeck M; Maurus S; Ricke J; Klingel K; Kääb S; Orban M; Massberg S; Hausleiter J; Grabmaier U
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e012220. PubMed ID: 33463366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Magnetic Resonance Follow-Up of Children After Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 With Initial Cardiac Involvement.
    Bartoszek M; Małek ŁA; Barczuk-Falęcka M; Brzewski M
    J Magn Reson Imaging; 2022 Mar; 55(3):883-891. PubMed ID: 34327751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance.
    Kotecha T; Knight DS; Razvi Y; Kumar K; Vimalesvaran K; Thornton G; Patel R; Chacko L; Brown JT; Coyle C; Leith D; Shetye A; Ariff B; Bell R; Captur G; Coleman M; Goldring J; Gopalan D; Heightman M; Hillman T; Howard L; Jacobs M; Jeetley PS; Kanagaratnam P; Kon OM; Lamb LE; Manisty CH; Mathurdas P; Mayet J; Negus R; Patel N; Pierce I; Russell G; Wolff A; Xue H; Kellman P; Moon JC; Treibel TA; Cole GD; Fontana M
    Eur Heart J; 2021 May; 42(19):1866-1878. PubMed ID: 33596594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis.
    Panopoulos S; Mavrogeni S; Vlachopoulos C; Sfikakis PP
    Rheumatology (Oxford); 2023 Apr; 62(4):1535-1542. PubMed ID: 36083014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance.
    von Knobelsdorff-Brenkenhoff F; Schüler J; Dogangüzel S; Dieringer MA; Rudolph A; Greiser A; Kellman P; Schulz-Menger J
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).
    Puntmann VO; Carerj ML; Wieters I; Fahim M; Arendt C; Hoffmann J; Shchendrygina A; Escher F; Vasa-Nicotera M; Zeiher AM; Vehreschild M; Nagel E
    JAMA Cardiol; 2020 Nov; 5(11):1265-1273. PubMed ID: 32730619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac MRI in Suspected Acute Myocarditis After COVID-19 mRNA Vaccination.
    Kravchenko D; Isaak A; Mesropyan N; Endler C; Bischoff L; Vollbrecht T; Pieper CC; Sedaghat A; Kuetting D; Hart C; Feisst A; Attenberger U; Luetkens JA
    Rofo; 2022 Sep; 194(9):1003-1011. PubMed ID: 35272355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced cine MR sequences in the assessment of myocardial hyperemia in acute myocarditis: can they help? A feasibility study.
    Laissy JP; Pezel T; Herbin C; Corino C; Bendriss A
    Heart Vessels; 2023 May; 38(5):662-670. PubMed ID: 36436026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging.
    Starekova J; Bluemke DA; Bradham WS; Eckhardt LL; Grist TM; Kusmirek JE; Purtell CS; Schiebler ML; Reeder SB
    JAMA Cardiol; 2021 Aug; 6(8):945-950. PubMed ID: 33443537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols.
    Chu GC; Flewitt JA; Mikami Y; Vermes E; Friedrich MG
    Int J Cardiovasc Imaging; 2013 Jun; 29(5):1077-83. PubMed ID: 23404383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
    Radunski UK; Lund GK; Säring D; Bohnen S; Stehning C; Schnackenburg B; Avanesov M; Tahir E; Adam G; Blankenberg S; Muellerleile K
    Clin Res Cardiol; 2017 Jan; 106(1):10-17. PubMed ID: 27388331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History of Myocardial Injury After COVID-19 Vaccine-Associated Myocarditis.
    Mustafa Alhussein M; Rabbani M; Sarak B; Dykstra S; Labib D; Flewitt J; Lydell CP; Howarth AG; Filipchuck N; Kealey A; Colbert J; Guron N; Kolman L; Merchant N; Bandali M; Bristow M; White JA
    Can J Cardiol; 2022 Nov; 38(11):1676-1683. PubMed ID: 35944800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Characterization by Mapping and Strain Cardiac MRI to Evaluate Myocardial Inflammation in Fulminant Myocarditis.
    Li H; Zhu H; Yang Z; Tang D; Huang L; Xia L
    J Magn Reson Imaging; 2020 Sep; 52(3):930-938. PubMed ID: 32080960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Magnetic Resonance Findings of Coronavirus Disease 2019 (COVID-19) Vaccine-Associated Myopericarditis at Intermediate Follow-Up: A Comparison with Classic Myocarditis.
    Dove ML; Slesnick TC; Oster ME; Hashemi S; Patel T; Wilson HC
    J Pediatr; 2023 Sep; 260():113462. PubMed ID: 37172812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.